~~<i id='F0EB1A457F'><strike id='F0EB1A457F'><tt id='F0EB1A457F'><pre id='F0EB1A457F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：explore 2025-09-29 22:48:51 - browse：52481

A sign of AdventHealth on its building in Orlando, Florida — coverage from STAT — Adobe

A lawsuit between a large hospital system and a dominant vendor that works for health insurance companies is getting a lot more heated — with one party calling the other an “economic parasite.”

The suit, between nonprofit hospital giant AdventHealth and MultiPlan, is now even attracting rare interest from the nation’s biggest hospital lobbyists.

The new, highly detailed legal filings also come right as MultiPlan and more than a dozen of the largest tax-exempt, nonprofit hospital systems are wooing investors at the J.P. Morgan Healthcare Conference. AdventHealth did not attend this year’s conference, but did so last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Biogen nominates mother of director’s child to replace him on board

focus

hotspot

entertainment

focus

AdobeInMay,aNationalPublicRadiostoryasked,“Canachatbothelppeoplewitheatingdisordersaswellasanotherhu

WSS

Body of missing toddler recovered in Delaware River days after flood: Police

Living organ donors deserve priority status for transplants

Biogen nominates mother of director’s child to replace him on board

Novo: Oral version of Ozempic leads to 15% weight loss

In new study, freeze

AbbVie dramatically boosts its spending on lobbying

hotspot

leisure time

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Hollywood unions extend contract negotiations for actors

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

FDA official pushes for dedicated emerging pathogens team

Cancer drug shortages should be causing more outrage

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

DIEP, the 'gold standard' of breast reconstruction, is under threat

Mom launches Girl Scout troop for LGBTQ youth in Texas

focus

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

The thinking behind the controversial eating disorder chatbot Tessa

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Patients, doctors are clashing about side effects of hormonal birth control

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

hotspot

entertainment

focus

focus